GSK Investigational Site

Mátraháza 3233

0 studies enrolling now · 4 studies all time

What they study most

Chemotherapy-Induced Nausea and Vomiting, Lung Cancer, Non-Small Cell, Nausea and Vomiting, Chemotherapy-Induced, Pulmonary Disease, Chronic Obstructive

Studies at this site

• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy — Completed
• Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer — Completed